Joseph Pidala

10.8k total citations · 1 hit paper
170 papers, 5.0k citations indexed

About

Joseph Pidala is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Joseph Pidala has authored 170 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Hematology, 46 papers in Public Health, Environmental and Occupational Health and 43 papers in Immunology. Recurrent topics in Joseph Pidala's work include Hematopoietic Stem Cell Transplantation (122 papers), Acute Lymphoblastic Leukemia research (42 papers) and Childhood Cancer Survivors' Quality of Life (39 papers). Joseph Pidala is often cited by papers focused on Hematopoietic Stem Cell Transplantation (122 papers), Acute Lymphoblastic Leukemia research (42 papers) and Childhood Cancer Survivors' Quality of Life (39 papers). Joseph Pidala collaborates with scholars based in United States, Canada and Germany. Joseph Pidala's co-authors include Claudio Anasetti, Stephanie J. Lee, Heather Jim, Madan Jagasia, Steven Z. Pavletic, Jeanne Palmer, Corey Cutler, Mary E.D. Flowers, Paul J. Martin and Xiaoyu Chai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Joseph Pidala

167 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

2015 280 citations Stephanie J. Lee, John Koreth et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph Pidala United States	39	3.5k	1.5k	1.2k	1.1k	871	170	5.0k
Christopher Bredeson Canada	46	4.5k 1.3×	1.0k 0.7×	1.6k 1.4×	1.9k 1.7×	802 0.9×	170	6.7k
Edward A. Copelan United States	31	3.9k 1.1×	1.0k 0.7×	1.3k 1.1×	1.4k 1.3×	658 0.8×	194	5.7k
Marcelo C. Pasquini United States	46	5.3k 1.5×	1.7k 1.1×	1.6k 1.4×	2.3k 2.1×	674 0.8×	246	7.6k
Steven L. McAfee United States	30	1.9k 0.5×	1.1k 0.8×	748 0.6×	1.2k 1.1×	538 0.6×	103	3.7k
Michael A. Pulsipher United States	47	4.5k 1.3×	1.5k 1.0×	2.1k 1.8×	2.4k 2.2×	1.2k 1.4×	253	7.6k
K. Scott Baker United States	40	2.3k 0.6×	765 0.5×	1.0k 0.9×	920 0.8×	1.0k 1.2×	162	4.7k
Ephraim P. Hochberg United States	42	1.2k 0.3×	987 0.7×	569 0.5×	1.9k 1.7×	396 0.5×	148	5.2k
Shernan G. Holtan United States	29	1.5k 0.4×	1.2k 0.8×	483 0.4×	1.0k 0.9×	296 0.3×	176	3.5k
Raymond J. Hutchinson United States	42	1.6k 0.5×	784 0.5×	1.9k 1.6×	1.3k 1.2×	1.5k 1.7×	136	5.6k
David Gómez‐Almaguer Mexico	29	1.9k 0.5×	523 0.4×	741 0.6×	579 0.5×	414 0.5×	335	3.0k

Countries citing papers authored by Joseph Pidala

Since Specialization

Citations

This map shows the geographic impact of Joseph Pidala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Pidala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Pidala more than expected).

Fields of papers citing papers by Joseph Pidala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Pidala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Pidala. The network helps show where Joseph Pidala may publish in the future.

Co-authorship network of co-authors of Joseph Pidala

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Pidala. A scholar is included among the top collaborators of Joseph Pidala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Pidala. Joseph Pidala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pidala, Joseph, Shernan G. Holtan, Kelly Walton, et al.. (2023). JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results. Blood. 142(Supplement 1). 2177–2177. 1 indexed citations

Gonzalez, Rebecca, Joseph Pidala, Aleksandr Lazaryan, et al.. (2023). Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 29(9). 577.e1–577.e9. 5 indexed citations

Brandon, Karen O., Maija Reblin, Joseph Pidala, et al.. (2022). A mindfulness-based stress management program for caregivers of allogeneic hematopoietic stem cell transplant (HCT) patients: Protocol for a randomized controlled trial. PLoS ONE. 17(4). e0266316–e0266316. 1 indexed citations

Pidala, Joseph, Kelly Walton, Hany Elmariah, et al.. (2021). Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results. Clinical Cancer Research. 27(10). 2712–2722. 15 indexed citations

Otoukesh, Salman, Hany Elmariah, Dongyun Yang, et al.. (2021). Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 28(2). 111.e1–111.e8. 12 indexed citations

Chin, Kuo‐Kai, Haesook T. Kim, Vincent T. Ho, et al.. (2021). Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience. Transplantation and Cellular Therapy. 27(12). 990.e1–990.e7. 14 indexed citations

Perez, Lia, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, et al.. (2021). A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention. Blood Advances. 5(13). 2740–2750. 9 indexed citations

Cusatis, Rachel, Kathryn E. Flynn, Sumithira Vasu, et al.. (2021). Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplantation and Cellular Therapy. 28(2). 112.e1–112.e9. 4 indexed citations

Abedin, Sameem, Mark A. Schroeder, Rizwan Romee, et al.. (2021). Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis. British Journal of Haematology. 195(3). 429–432. 10 indexed citations

10.

Lee, Stephanie J., Franco Locatelli, Francis Ayuk, et al.. (2021). Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT). Blood. 138(Supplement 1). 3909–3909. 1 indexed citations

11.

Dehn, Jason, Stephen R. Spellman, Carolyn Katovich Hurley, et al.. (2019). Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 134(12). 924–934. 173 indexed citations

12.

Pidala, Joseph, Tatenda Mupfudze, Juliet N. Barker, et al.. (2019). Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program. Biology of Blood and Marrow Transplantation. 25(12). 2501–2506. 9 indexed citations

13.

Vinci, Christine, et al.. (2018). Understanding preferences for a mindfulness-based stress management program among caregivers of hematopoietic cell transplant patients. Complementary Therapies in Clinical Practice. 33. 164–169. 7 indexed citations

14.

Mehta, Rohtesh S., Shernan G. Holtan, Tao Wang, et al.. (2017). Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients. Blood. 130. 2053–2053. 1 indexed citations

15.

Khimani, Farhad, Erin Dean, Brian C. Betts, et al.. (2017). Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention. Bone Marrow Transplantation. 52(7). 1003–1009. 8 indexed citations

16.

Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations

17.

Palmer, Jeanne, Jeannine S. McCune, Miguel‐Angel Perales, et al.. (2016). Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. Biology of Blood and Marrow Transplantation. 22(11). 1915–1925. 110 indexed citations

18.

Paczesny, Sophie, Frances T. Hakim, Joseph Pidala, et al.. (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report. PMC. 1 indexed citations

19.

Jim, Heather, et al.. (2013). Quality of life associated with sirolimus for prevention of graft-versus-host disease: results from a randomized trial. Haematologica. 99(3). 548–553. 7 indexed citations

20.

Pidala, Joseph & Claudio Anasetti. (2010). Glucocorticoid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 16(11). 1504–1518. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact